IRAK4 and neoplasm: In a mouse xenograft model of ABC DLBCL, ND-2158 (an IRAK-4 inhibitor) decreased tumor growth without excess toxicity and significantly reduced phosphorylation of IRAK-4 (at Thr-345/Ser-346) within the tumors (42).